Medication Monitor

Generic Name (Trade Name—Company)
May 1, 2011

Lansoprazole delayed-release ODT

(no trade name—Teva)
Withdrawn because of disintegration problems

Teva has voluntarily withdrawn its lansoprazole delayed-release orally disintegrating tablets (ODT) after FDA received reports that the tablets clogged and blocked oral syringes and feeding tubes, including gastric and jejunostomy tubes. The ODT tablets reportedly do not fully disintegrate fully when water is added or disintegrate and later form clumps that clog oral syringes and feeding tubes.